| Old Articles: <Older 6971-6980 Newer> |
|---|
 |
The Motley Fool
December 16, 2010
Travis Hoium |
Bio-Reference Laboratories Shares Plunged: What You Need to Know Shares of laboratory service provider Bio-Reference Laboratories fell 10% briefly today after the company released earnings.   |
The Motley Fool
December 16, 2010
Seth Jayson |
Why the Street Should Love LabCorp's Earnings With questionable cash flows amounting to only 7.4% of operating cash flow, LabCorp's cash flows look clean. |
The Motley Fool
December 16, 2010
Robert Buderi |
Microsoft and Sentillion: A Progress Report on a Crucial Health IT Acquisition How is the integration going? |
The Motley Fool
December 15, 2010
Brian Orelli |
Beautiful Efficacy, Wrong Pill Lexicon Pharmaceuticals presented beautiful data showing a pill it gave rheumatoid arthritis patients decreased symptoms in 49% of patients. Unfortunately, the pill was a dummy pill with no active ingredient. |
The Motley Fool
December 15, 2010
Seth Jayson |
Does This Mean Hospira Will Burn You? Investors should watch Hospira's top line carefully during the next quarter or two. |
The Motley Fool
December 15, 2010
Seth Jayson |
Here's How Varian Medical Systems Is Making So Much for You Here's the margin picture for Varian Medical Systems over the past few years. |
InternetNews
December 14, 2010 |
White House Goes to War on Fake Online Drugs Obama administration officials announce nonprofit organization devoted to combating the trafficking of fake online goods, which they say pose both health hazards and economic threats. |
The Motley Fool
December 14, 2010
Brian Orelli |
An Ounce of Prevention, a Pound of Blockbuster Sales Amgen's Xgeva recently gained Food and Drug Administration approval to treat cancer patients that have bone metastasis. |
The Motley Fool
December 14, 2010
Travis Hoium |
Lexicon Pharmaceuticals Shares Plunged: What You Need to Know Lexicon Pharmaceuticals shares fell as much as 14% in intraday trading on disappointing results of its rheumatoid arthritis drug test. |
The Motley Fool
December 14, 2010
Travis Hoium |
Emergency Medical Services Shares Popped: What You Need to Know Emergency Medical Services shares jumped 18% today after the company announced it was reviewing strategic alternatives. |
| <Older 6971-6980 Newer> Return to current articles. |
